These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3884056)

  • 21. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
    Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
    Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the elution pattern of the serum and CSF prolactin fractionated by gel filtration chromatography in cases of bromocriptine-resistant prolactinoma].
    Sakamoto T; Kowada M; Hasegawa H; Ishino Y; Mineura K; Wakisaka A; Fukushima M
    Neurol Med Chir (Tokyo); 1987 Mar; 27(3):195-201. PubMed ID: 2442642
    [No Abstract]   [Full Text] [Related]  

  • 23. Cerebrospinal fluid rhinorrhea caused by bromocriptine therapy of prolactinoma.
    Holness RO; Shlossberg AH; Heffernan LP
    Neurology; 1984 Jan; 34(1):111-3. PubMed ID: 6537833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clozapine in treatment of bromocriptine-induced psychosis.
    Al-Semaan YM; Clay HA; Meltzer HY
    J Clin Psychopharmacol; 1997 Apr; 17(2):126-8. PubMed ID: 10950481
    [No Abstract]   [Full Text] [Related]  

  • 25. Enlargement of a prolactin-secreting pituitary microadenoma during bromocriptine treatment. Case report.
    Crosignani PG; Mattei A; Ferrari C; Giovanelli MA
    Br J Obstet Gynaecol; 1982 Feb; 89(2):169-70. PubMed ID: 7066250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dramatic and rapid shrinkage of a massive invasive prolactinoma with bromocriptine: a case report.
    Clayton RN; Webb J; Heath DA; Dunn PJ; Rolfe EB; Hockley AD
    Clin Endocrinol (Oxf); 1985 May; 22(5):573-81. PubMed ID: 4028456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study.
    Bergström M; Muhr C; Lundberg PO; Bergström K; Gee AD; Fasth KJ; Långström B
    J Comput Assist Tomogr; 1987; 11(5):815-9. PubMed ID: 3498743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual function in prolactinoma patients treated with bromocriptine.
    Moster ML; Savino PJ; Schatz NJ; Snyder PJ; Sergott RC; Bosley TM
    Ophthalmology; 1985 Oct; 92(10):1332-41. PubMed ID: 4069600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A case of toxic psychosis caused by bromocriptine].
    Jimeno Valdés A; Ruiz Otazo AM; Jimeno Bulnes N
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1989; 17(6):386-90. PubMed ID: 2698595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of hypophyseal prolactinoma with treatable delusions of dermatozoiasis.
    Takeda M; Tanino S; Nishinuma K; Matsubayashi T; Yamashita S; Nishimura T
    Acta Psychiatr Scand; 1985 Nov; 72(5):470-5. PubMed ID: 4091030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of psychosis and delirium following withdrawal from triazolam.
    Heritch AJ; Capwell R; Roy-Byrne PP
    J Clin Psychiatry; 1987 Apr; 48(4):168-9. PubMed ID: 3558332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnancy after combined treatment with bromocriptine and tamoxifen in two patients with pituitary prolactinomas.
    Koizumi K; Aono T
    Fertil Steril; 1986 Aug; 46(2):312-4. PubMed ID: 3089843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [From the determination of prolactin to use of its inhibitor: bromocriptine].
    Schaison G; Georges D; Coustenoble J
    Sem Hop; 1978 Feb; 54(4):218-9. PubMed ID: 208171
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term bromocriptine treatment for prolactin-secreting macroadenoma.
    Huseman CA; Rizk G; Hahn F
    Am J Dis Child; 1986 Dec; 140(12):1216-7. PubMed ID: 3776935
    [No Abstract]   [Full Text] [Related]  

  • 35. Impaired pituitary response to bromocriptine suppression: reversal after bromocriptine plus tamoxifen.
    Völker W; Gehring WG; Berning R; Schmidt RC; Schneider J; von zur Mühlen A
    Acta Endocrinol (Copenh); 1982 Dec; 101(4):491-500. PubMed ID: 7158226
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of bromocriptine on DNA synthesis, growth and hormone secretion of spontaneous pituitary tumours in the rat.
    Prysor-Jones RA; Jenkins JS
    J Endocrinol; 1981 Mar; 88(3):463-9. PubMed ID: 7217831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic bromocriptine treatment during pregnancy in women with macroprolactinomas: report of 13 pregnancies.
    de Wit W; Coelingh Bennink HJ; Gerards LJ
    Br J Obstet Gynaecol; 1984 Nov; 91(11):1059-69. PubMed ID: 6498119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Return of menstruation and normalization of prolactin in hyperprolactinemic women with bromocriptine-induced pregnancy.
    Rasmussen C; Bergh T; Nillius SJ; Wide L
    Fertil Steril; 1985 Jul; 44(1):31-4. PubMed ID: 4007192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolactinomas.
    Grossman A; Besser GM
    Br Med J (Clin Res Ed); 1985 Jan; 290(6463):182-4. PubMed ID: 3917745
    [No Abstract]   [Full Text] [Related]  

  • 40. Does bromocriptine jeopardise the response to later yttrium-90 irradiation for macroprolactinemias?
    Ch'ng JL; Jung RT; Mashiter K; Bowley NB; Joplin GF
    Lancet; 1982 Nov; 2(8307):1099. PubMed ID: 6127559
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.